Immuno-based botulinum toxin serotype A activity assays | Patent Publication Number 20210171614

US 20210171614 A1
Patent NumberUS 11261240 B2
Application Number17124747
Filled DateDec 17, 2020
Priority DateMar 14, 2008
Publication DateJun 10, 2021
Original AssigneeAbbvie Inc.
Current AssigneeAllergan
Inventor/ApplicantsD. Diane Hodges
Kei Roger Aoki
Patton Garay
Ester Fernandez-Salas
Patton E. Garay
Joanne Wang
Lina S. Wong
Lina Wong
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.